Akeso Biomedical, Inc.
Burlington, MA · Founded 2014 · CIK 0001604559 · Biotech · Private
Novel iron-based antimicrobial compounds (Fe3C) to combat bacterial infections and foodborne pathogens
akesobiomedical.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $2.1M
- 8 Form D · Jun 2023
- 40 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 35
- 14 granted · 21 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201320152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $250,000 | |
| Private capital raised | Form D · SEC | $225,000 | |
| Private capital raised | Form D · SEC | $535,000 | |
| Private capital raised | Form D · SEC | $5,000,000 | |
| Private capital raised | Form D · SEC | $149,285 | |
| Private capital raised | Form D · SEC | $597,325 | |
| Private capital raised | Form D · SEC | $573,905 | |
| Private capital raised | Form D · SEC | $25,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1763 | TellBio, Inc. | — | $11M |
| 1764 | Trilo Therapeutics, Inc. | — | — |
| 1765 | Phaeno Inc | — | — |
| 1766 | Akeso Biomedical, Inc. | — | $2.1M |
| 1767 | SegueTX-Pancreatic Cancer, L.L.C. | — | — |
| 1768 | Abfero Pharmaceuticals, Inc. | — | $1.5M |
| 1769 | CARTHRONIX, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- R. GoforthDirector
- Robert GoforthDirector
- Mark KiddExecutive Officer
- Greg LeeDirector
- Kevin OhashiDirector
- Bernard PrusaczykDirector · Executive Officer
- Scott RothDirector
- Anthony SinskeyDirector
- Mark WagstaffExecutive Officer
- Simon WilliamsDirector · Executive Officer
Patents
- Biofilm Inhibiting Compositions Enhancing Weight Gain In Livestockgranted
- Biofilm Inhibiting Compositions Enhancing Weight Gain In Livestockapplication
- Biofilm Inhibiting Compositions Enhancing Weight Gain In Livestockgranted
- Feed Compositions Enhancing Zootechnical Performance In Livestockapplication
- Biofilm Inhibiting Compositions Enhancing Weight Gain In Livestockgranted
- Antimicrobial Preparation And Uses Thereofgranted
- Antimicrobial Compounds And Compositions, And Uses Thereofapplication
- Biofilm Inhibiting Compositions Enhancing Weight Gain In Livestockgranted
- Reduction Of Gastrointestinal Tract Colonisation By Campylobacterapplication
- Biofilm Inhibiting Compositions Enhancing Weight Gain In Livestockgranted
- Antimicrobial Compounds And Compositions, And Uses Thereofgranted
- Biofilm Inhibiting Compositions Enhancing Weight Gain In Livestockgranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.